Medicare enrollees are paying excess of their prescription-drug plans for dozens of medicine coated below Medicare Half D, in line with a brand new research from the U.S. Authorities Accountability Workplace.
For 79 medication studied by the GAO, Medicare sufferers’ 2021 spending totaled $21 billion — roughly quadruple the quantity that Half D plans spent on these medication, after accounting for “rebates,” or reductions that drugmakers usually pay to Half D plan sponsors or the prescription-drug middlemen generally known as pharmacy-benefit managers.
…